BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 6, 2026
Home » Topics » Infection » Coronavirus

Coronavirus
Coronavirus RSS Feed RSS

Regulatory front for Aug. 17, 2020

Aug. 17, 2020
The latest global regulatory news, changes and updates affecting medical devices and technologies, including: Becton Dickinson, Cartiva, C.R. Bard, Stryker ENT.
Read More

Regulatory actions for Aug. 17, 2020

Aug. 17, 2020
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Baxter.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Angiodynamics, Anthem, Avateramedical, Brain Scientific, Carterra, Endospan, Forwardttc, Genmark Diagnostics, Hengrui Therapeutics, Magle Chemoswed, Microbot Medical, Quest Diagnostics, Sectra, Sirtex Medical, Swift Biosciences, Thermo Fisher Scientific, Tissue Regenix Group, Todos Medica.
Read More
Coronavirus microscopic model

CNBG unveils interim data of inactivated vaccine candidate for COVID-19

Aug. 17, 2020
By Elise Mak
Chinese state-backed vaccine developer China National Biotec Group (CNBG), of Beijing, published an interim analysis of randomized phase I/II trials of its inactivated SARS-CoV-2 vaccine candidate in the Journal of the American Medical Association last week.
Read More
R&D money

Biopharmas continue to ramp up their R&D investments, analysis finds

Aug. 17, 2020
By Peter Winter
According to an analysis conducted by BioWorld of the second-quarter 2020 financial reports filed by 120 public biopharmaceutical companies with market caps greater than $1 billion, and excluding big pharma companies, the amount that was invested in research and development during the period increased by 14% compared to the same six-month period last year.
Read More

ICYMI: Week in Review, Aug. 10-14, 2020

Aug. 17, 2020
By Peter Winter
A quick look back at top stories.
Read More

Regulatory front for Aug. 17, 2020

Aug. 17, 2020
The latest global regulatory news, changes and updates affecting biopharma.
Read More

Other news to note for Aug. 17, 2020

Aug. 17, 2020
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abeona, Adgero, Aicuris, Alnylam, Arvelle, Bioaegis, BMS, Bold, Boundless Bio, Carsgen, Dragonfly, Delmar, Enzon, Hengrui, Hifibio, Kiadis, Memo, Organovo, Ose, Pluristem, Taysha, Thermo Fisher, Xbiotech.
Read More

In the clinic for Aug. 17, 2020

Aug. 17, 2020
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alkermes, Amplyx, Ansun, Ascletis, Axcella, Azurrx, Betagenon/Balticgruppen, Chiasma, Clovis, Enterprise, GNI Group, I-Mab, Merck, Neuroptika, Novavax, Precigen, Syndax, Unity.
Read More

Regulatory actions for Aug. 14, 2020

Aug. 17, 2020
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Adamis, Kempharm, Mesoblast, TLC, Verona.
Read More
Previous 1 2 … 391 392 393 394 395 396 397 398 399 … 551 552 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 2, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 31, 2026
  • Cancer and blood cells

    Hematopoietic stem cell research points to leukemia’s early roots

    BioWorld Science
    Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
  • Hengrui discovers new Nav1.8 blockers

    BioWorld Science
    Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
  • Illustration of a nerve cell with DNA double helix

    Molecular signatures show subtypes in neurodegenerative diseases

    BioWorld Science
    Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing